|
|
Exchange: |
American Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
34,270,000 |
Market
Cap: |
40.27(M) |
Last
Volume: |
129,549 |
Avg
Vol: |
128,336 |
52
Week Range: |
$1.01 - $3.325 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : 3.3 |
Insider 6 Months : 3.3 |
Insider 3/6 Months : 7 |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Apyx Medical is an energy technology company. In its Advanced Energy segment, Co.'s product portfolio consists of its Helium Plasma Technology that is marketed and sold as Renuvion® in the cosmetic surgery market and J-Plasma® in the hospital surgical market. Co.'s primary focus is on the cosmetic surgery market where Renuvion® provides plastic surgeons, facial plastic surgeons and cosmetic physicians an ability to provide controlled heat to the tissue. In its Original Equipment Manufacturing (OEM) segment, Co. produces generators and related accessories for medical device manufacturers through OEM agreements, as well as start-up companies with the need for its energy-based designs.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
5,336 |
5,336 |
57,836 |
57,836 |
Total Buy Value |
$6,030 |
$6,030 |
$90,005 |
$90,005 |
Total People Bought |
1 |
1 |
2 |
2 |
Total Buy Transactions |
1 |
1 |
3 |
3 |
Total Shares Sold |
0 |
0 |
0 |
30,000 |
Total Sell Value |
$0 |
$0 |
$0 |
$226,800 |
Total People Sold |
0 |
0 |
0 |
1 |
Total Sell Transactions |
0 |
0 |
0 |
2 |
End Date |
2024-06-27 |
2024-03-26 |
2023-09-26 |
2022-09-26 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Makrides Andrew |
Director |
|
2018-11-08 |
4 |
GD |
$6.84 |
$41,040 |
D/D |
6,000 |
605,972 |
|
- |
|
Mccarthy John J. Iii |
Chief CommercializationOfficer |
|
2016-08-17 |
4 |
B |
$3.30 |
$299,475 |
D/D |
90,750 |
115,750 |
2.74 |
- |
|
Davidson Scott Richard |
Director |
|
2016-07-28 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,680,000 |
|
- |
|
Mccarthy John J. Iii |
Chief Commercialization Office |
|
2015-12-22 |
4 |
B |
$1.98 |
$49,428 |
D/D |
25,000 |
25,000 |
2.74 |
- |
|
Citronowicz Moshe |
Sr. V.P. of Operations |
|
2015-12-21 |
4 |
B |
$1.84 |
$36,774 |
D/D |
20,000 |
426,504 |
2.74 |
- |
|
Gershon Robert |
Chief Executive Officer |
|
2015-12-21 |
4 |
B |
$1.82 |
$18,168 |
D/D |
10,000 |
30,000 |
2.81 |
- |
|
Gershon Robert |
Chief Executive Officer |
|
2015-08-14 |
4 |
B |
$2.39 |
$47,800 |
D/D |
20,000 |
20,000 |
0.01 |
- |
|
Great Point Partners Llc |
Director by deputization |
|
2015-03-17 |
4 |
A |
$2.50 |
$1,200,000 |
I/I |
480,000 |
480,000 |
|
- |
|
Makrides Andrew |
Director |
|
2014-09-19 |
4 |
D |
$4.35 |
$53,248 |
D/D |
(12,241) |
611,972 |
|
- |
|
Makrides Andrew |
Director |
|
2014-09-19 |
4 |
OE |
$2.13 |
$53,250 |
D/D |
25,000 |
624,213 |
|
- |
|
Saron J Robert |
President |
|
2014-09-19 |
4 |
A |
$4.35 |
$26,626 |
D/D |
6,121 |
393,698 |
|
- |
|
Saron J Robert |
President |
|
2014-09-19 |
4 |
OE |
$2.13 |
$26,625 |
D/D |
12,500 |
399,819 |
|
- |
|
37 Records found
|
|
Page 2 of 2 |
|
|